Novartis Stiftung für medizinisch-biologische Forschung: Bewilligte

Novartis Stiftung für medizinisch-biologische Forschung: Bewilligte Projekte 2006
No
Name
Institut
Projekt
06A02
Trendelenburg M., Dr.
Innere Medizin B & Klinische Immunologie,
Universitätsspital Basel
SLE cohort: The role of autoantibodies against complement C1q in the follow-up
06A03
Heizmann C.W., Prof.
Abt. Für Klinische Chemie und Biochemie,
Universitäts-Kinderklinik Zürich
Myocardial calcium signalling and the importance of S100A1 in pathogenesis
06A04
Berger Th., PD Dr.
Inst. Für Physiologie, Universität Bern
Informationsverarbeitung in Neuronen und Netzwerken in kortikalen Hirnschnitten unter in vivo-ähnlichen Bedingungen
06A08
Siler U., Dr.
Abt. Immunologie/Hämatologie/KMT,
Kinderspital Zürich
Development of a gammaretroviral vector for gene replacement therapy of the p47 phox-deficient form of chronic
granulomatous disease (CGD)
06A09
Thome-Miazza M.,
Prof.
Dép. de Biochimie, Université de Lausanne
Analysis of signaling pathways that control NF-kB activation and cytokine production in monocytes
06A10
Thöny B., Prof.
Abt. Für Klinische Chemie und Biochemie,
Universitäts-Kinderklinik Zürich
Genetherapy for phenylketonuria (PKU) with an hepatic rAAV-8 vector: from mice to clinic
06A11
Gross N., PD Dr.
Lab. De Recherche en Oncologie Pédiatrique,
Dép. Médico-chirurgical de Pédiatrie, CHUV,
Lausanne
An in vitro and in vivo study to target neuroblastoma apoptosis and angiogenesis by histone deacetylase inhibitors
06A14
De Moerloose Ph.,
Prof.
Div. d’Angiologie et d’Hémostase, Hôpital
Cantonal Univ. de Genève
Role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies
06A16
Féraille E., PD Dr.
Service de Néphrologie, fondation pour
recherches médicales, Université de Genève
Role of local pro-inflammatory stimuli in the pathogenesis of sodium retention in nephrotic syndrome
06A19
Orend G., PD Dr.
Inst. Für Biochemie und Genetik, Zentrum für
Biomedizin, DKBW, Universität Basel
Analysis of the role of FAK, RhoA and tropomyosin-1 in cell adhesion signaling downstream of syndecan-4 in a tenascin-C
context
06A20
Loewith R., Prof.
Dép. de Biologie Moléculaire, Université de
Genève
SCH9 and YPK2 as TOR complexes effectors
06A24
Thelen M., Prof. PD
Dr.
Istituto di Ricerca in Biomedicina, Bellinzona
Chemokine receptor mediated signal transduction
06A28
Heuer N., Dr. & Hatz
Ch., Prof.
Swiss Tropical Institute, Basel
Antiretroviral Therapy at St. Francis designated district Hospital: Treatment outcome depending on the baseline CD4 cell
count of late presenters
06A29
Went Ph., Dr. &
Dirnhofer S., Prof.
Inst. Für Pathologie, Universität Basel
Genotype - phenotype correlation in peripheral T-cell lymphomas
06B33
Heinimann K., PD Dr.
Forschungsgruppe Humangenetik, Abt.
Medizinische Genetik UKBB, Zentrum für
Biomedizin DKBW, Universität Basel
Gene expression profiling in autosomal recessive Hutchinson-Gilford progeria syndrome (HGPS)
06B36
James R., Prof.
Dept. Of Internal Medicine, Medical Faculty,
University of Geneva
The role of paraoxonase gene family in protection against bacterial infection
06B37
Serra A., Dr.
Klinik für Nephrologie, Universitätsspital Zürich
Inhibition of the mammalian target of rapamycin (mTOR) to slow the progression of autosomal dominant polycystic
kidney disease (ADPKD)
06B39
Hemphill A., Prof.
Institut für Parasitologie, Vetsuisse Fakultät,
Universität Bern
Echinococcus and echinococcosis: development of novel treatments for an old disease
06B41
Kapfhammer J., Prof.
Anatomisches Institut, Universität Basel
Synaptic and dendritic development of the cerebellar Purkinje cells in GluRδ2 (GRID2) mutant mice: Focus on
autophagy and glutamate receptors
06B43
Huwiler A., Prof.
Institut für Pharmakologie, Universität Bern
Regulatory functions of sphingolipids in inflammatory eicosanoid synthesis in macrophages
06B44
Ruiz i Altaba A., Prof.
, Faculté de Médecine, Dép. de Médecine
Génétique et Développement, Université de
Genève
Characterization and imaging of Gli1+cells of the subventricular zone of mouse brain
06B45
Brink M., Prof.
Dept. Für Klinische und Biologische
Wissenschaften (DKBW), Dept. Forschung,
Universitätsspital Basel
Transcriptional Regulation of the Urocortin II Gene in the Cardiovascular System
06B48
Boyman O., Dr.
Institut Ludwig de Recherche sur le Cancer,
Université de Lausanne
Use of interleukin 2 in CD8+ cell-based vaccination
06B50
Nadal D., Prof.
Infektiologie, Universitätskinderklinik Zürich
Regulation of Epstein-Barr virus lytic infection by latent membrane protein (LMP)2A and LMP2B
06B51
Meyer H., Dr.
Insitut für Biochemie, ETH Zürich
Regulation of mitosis in human cells by valosin-containing protein (VCP)/p97
06B52
Papassotiropoulos A.,
Prof.
Abt. Für Psychiatrische Forschung, Universität
Zürich
The influence of cAMP-dependent protein kinase (PRKACG) on human memory
06B53
Stickel F., PD Dr.
Institut für Klinische Pharmakologie, Universität
Bern
Auswirkung chronischer Alkoholzufuhr auf die Leberfibroseprogression bei Leptinrezeptor-defekten, adipösen fa/faZucker-Ratten
06B54
Kretz R., Prof.
Dept. Medizin, Abt. Anatomie, Universität
Fribourg
TUP-FOS
06C56
Hohl D., Prof.
Service de Dermatologie, CHUV, Lausanne
Développement d’un modèle organotypique modulable in vitro pour l’ichtyose lamellaire de type et l’ichtyose létale arlequin
06C59
Sommer Lukas, Prof.
Insitut für Zellbiologie, ETH Zürich
The developmental and therapeutic potential of neural-crest-derived adult stem cells from the skin
06C62
Lang U., PD Dr.
Service d’endocrinologie, diabétologie et
nutrition, HUG, Genève
Role of HDL in antiapoptotic and hypertrophic responses in ventricular cardiomyocytes
06C64
Stein J.V., Dr.
Theodor Kocher Institut, Universität Bern
Developing optical projection tomography for three-dimensional tissue analysis of secondary lymphoid organs
06C67
Wymann M., Prof.
Inst. für Biochemie und Genetik, Dept. für
Klinische und Biologische Wissenschaften,
Zentrum für Biomedizin, Universität Basel
Role of class I PI3Ks in natural killer cells
06C69
Zurn A., PD Dr.
Service de Chirurgie Expérimentale, CHUV,
Faculté de Biologie et Médecine, Lausanne
Molecular analysis of the glial response to injury: use of laser capture microdissection and real-time RT-PCR to evaluate the
regulation of candidate molecules involved in axonal growth-inhibition
06C71
Swartz M., Prof.
Institute of Bioengineering, School of Life
Sciences, EPFL, Lausanne
Tumor cell homing into the lymphatics via autologous chemokine signaling and interstitial flow
06C73
Giusti V., PD Dr.
Service d?Endocrinologie, Diabétologie et
Métabolisme, CHUV, Université de Lausanne
Role of the 11β-hydroxysteroid dehydrogenase in the pathologenesis of obesity and the metabolic syndrome
06C77
Fraefel C., PD Dr.
Virologisches Institut, Vetsuisse Fakultät,
Universität Zürich
Adeno-associated virus-mediated inhibition of helper virus replication: what is the role of Rep-mediated effects on the host
cell?
06C79
Geisler M., Prof.
Inst. Für Pflanzenbiologie, Molekulare
Pflanzenphysiologie, Universität Zürich
Watching TWISTED DWARF1 at work: Imaging p-glycoprotein-mediated auxin transport
06C81
Neuhauss S., Prof.
Zoologisches Institut, Universität Zürich
Adult Zebrafish as model organism for retinal diseases
06C82
Bochaton-Piallat M.L., PD Dr.
Dép. de Pathologie et Immunologie, Faculté de
Médecine, CMU, Université de Genève
Human atherosclerotic plaque and restenostic lesion characterization: role of S100A4, a marker of activated smooth muscle
cells
06C83
Trampuz A., Dr.
Klinik für Infektiologie & Spitalhygiene,
Universitätsspital Basel
Calorimetry - A novel method for rapid detection of microorganisms in patient blood and other body fluids
06C84
Tichelli A., Prof. &
Kalberer Ch., Dr.
Hämatologie Labor und Stem Cell
Transplantation Team, Universitätsspital Basel
Development of clinical immunotherapy with activated natural killer cells for acute leukemia